Leonteq Securities’s Calliditas Therapeutics CALT Stock Holding History
Bought
Maintained
Sold
Other funds holding CALT
ECM
Leonteq Securities's CALT Position: Q1 2021 in Review
Leonteq Securities sold out of Calliditas Therapeutics (CALT) in Q1 2021, closing a stake of 1,000 shares — an estimated $34K sold.
Leonteq Securities first reported a position in CALT in Q4 2020 and held it in 1 quarter. The position peaked at $34K in Q4 2020. 14 funds tracked by Wall St. Rank hold CALT as of Q1 2021.
- Leonteq Securities reported no remaining Calliditas Therapeutics position as of Q1 2021 after selling out during the quarter.
- Leonteq Securities sold 1,000 Calliditas Therapeutics shares in Q1 2021, an estimated $34K.
- Leonteq Securities first reported a position in Calliditas Therapeutics in Q4 2020 and held it in 1 quarter.
- Leonteq Securities's Calliditas Therapeutics position peaked at $34K in Q4 2020.
- 14 funds tracked by Wall St. Rank held Calliditas Therapeutics as of Q1 2021.
Based on Leonteq Securities's 13F filing for Q1 2021, filed 26 Mar 2026.